ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

8 links1 made here, not in the record8 judgments2 judges (the rules as one: Rule based)0 record changes seen
Claude Opus 5.5Rule basedMade here
Oct 19Oct 26Nov 2Nov 9Nov 16TodayNCT07643623Neoadjuvant and AdjuvantTherapy Studies ofSintilimab Combined WithChemotherapy With orWithout Ipilimumab N01 inResectableGastric/GastroesophagealInnovent Biopharmaceutical TecPhase 2/Phase 3 · recruitingRECORDThe record itselfVersions seen nightly since Sep 25, 2…›No new version seen since tracking began Sep 25, 2026.CONDITIONSResectable Gastric/Gastroes…No longer in the registry's filing›Nov 14 · Rule based · Not readNot readDRUGSTegafurEntry “tegafur, Gimeracil and Oteraci…›Nov 18 · Rule based · BackgroundBackgroundGimeracilEntry “tegafur, Gimeracil and Oteraci…›Nov 18 · Rule based · BackgroundBackgroundINT004690Entry “tegafur, Gimeracil and Oteraci…›Nov 18 · Rule based · BackgroundBackgroundSintilimabIntervention entry›Nov 18 · Rule based · TestedTestedIpilimumab N01Intervention entry›Nov 18 · Rule based · TestedTestedOxaliplatinEntry “Oxaliplatin for injection”, re…›Nov 18 · Rule based · BackgroundBackgroundIpilimumabMade here · Found by reading; no entr…›Nov 2 · Claude Opus 5.5 · TestedTested

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

Ipilimumab

Made here1 judgment on this link
NCT07643623gives it, found by reading the recordIpilimumabDefined by Claude Opus 5.5Nov 2, 2026, 8:21 AM UTC
Role in the study, from the registry to what was judged
RegistryNot in the recordno intervention entry names it
→judged

All judgments on this study

WhenLinkJudgeDecisionState
Nov 2Ipilimumabmade hereClaude Opus 5.5TestedCurrent
Nov 14Resectable Gastric/Gastroesophageal Junction AdenocarcinomaRule based · condition-kind ruleNot readCurrent
Nov 18TegafurRule based · role ruleBackgroundCurrent
Nov 18GimeracilRule based · role ruleBackgroundCurrent
Nov 18INT004690Rule based · role ruleBackgroundCurrent
Nov 18SintilimabRule based · role ruleTestedCurrent
Nov 18Ipilimumab N01Rule based · role ruleTestedCurrent
Nov 18OxaliplatinRule based · role ruleBackgroundCurrent

The rules, in plain words

“Rule based” means one of these decided, not a model or a person. Each runs every night over every study.

Which drugs a study tests

Reads each treatment the study lists and the arms it is in. A drug only in the experimental arm is tested. A drug in every arm while something else changes between the arms is given beside it. A drug only in the control arm is the comparator. Placebo, procedures and usual care are known by name.

Where the whole record has been read, that reading's answer replaces the rule's.

How a condition link is counted

For each condition a study is filed under: whether it is the study's own condition at the finest the study states it, a wider one, a general category, or filed by mistake; and whether it is the main condition, a setting the study names, or only how it was filed.

A decision on file for one study overrides it, with who made it and when.